Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
07 May 2015 IMPAKT 2015 News: PI3 Kinase and CDK4/6 Inhibitors Are Highly Active in ER-Positive Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: Incidence of Breast Cancer Oncogenes Higher in the PIK3K/AKT Signalling Pathway than in the MAPK Pathway Breast cancer - Translational research
07 May 2015 IMPAKT 2015 News: Using a Biomarker for Neoadjuvant Bevacizumab Response to Guide Treatment Is Cost Effective in Breast Cancer Breast cancer - Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: Analysis of Large Dataset Shows Improved Concordance of Local and Central HER2 Status Breast cancer - Pathology/Molecular biology
07 May 2015 IMPAKT 2015 News: AP-2gamma Tumour Expression Is a New Biomarker for Resistance to Endocrine Therapy in Patients with Metastatic Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: Outcome in Male Patients with Breast Cancer Varies According to Tumour Subtypes Based upon Receptor Expression Breast cancer
07 May 2015 IMPAKT 2015 News: Gene Expression Signatures May Signal Clinical Activity of Palbociclib in Patients with Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
28 Apr 2015 European Medicine Agency Recommends Refusal of the Marketing Authorisation for Dasiprotimut-T Haematologic malignancies - Immuno-oncology
27 Apr 2015 FDA Approves Ramucirumab for Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
24 Apr 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Nivolumab Melanoma - Immuno-oncology
22 Apr 2015 Pembrolizumab Shows Antitumour Activity in Patients with Advanced NSCLC Lung and other thoracic tumours - Immuno-oncology
21 Apr 2015 Phase III Randomised Trial Shows Pembrolizumab Superiority When Compared to Ipilimumab in Patients with Advanced Melanoma Melanoma - Immuno-oncology
17 Apr 2015 ELCC 2015 News: Detection of EGFR T790M Mutation from Circulating Tumour DNA in Urine of Patients with Metastatic NSCLC Translational research - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: DNA Blood Test Detects Lung Cancer Mutations Translational research - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: One in Four Advanced Lung Cancer Patients Tested for EGFR Mutations Started on First-line Treatment Before Test Results Available Bioethics, legal and economic issues - Lung and other thoracic tumours